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Summary. Knowledge in viral oncology has made considerable progress in the field of cancer fight. However, the role of 
bacteria as mediators of oncogenesis has not yet been elucidated. As cancer still is the leading cause of death in developed 
countries, understanding the long-term effects of bacteria has become of great importance as a possible means of cancer 
prevention. This study reports that Chlamydia pneumoniae infection induce transformation of human mesothelial cells. Mes1 
cells infected with C. pneumoniae at a multiplicity of infection of 4 inclusion-forming units/cell showed many intracellular 
inclusion bodies. After a 7-day infection an increased proliferative activity was also observed. Real-time PCR analysis revealed 
a strong induction of calretinin, Wilms’ tumour gene 1, osteopontin, matrix metalloproteinases-2, and membrane-type 1 metal-
loproteinases gene expression in Mes1 cell, infected for a longer period (14 days). The results were confirmed by western blot 
analysis. Zymography analysis showed that C. pneumoniae modulated the in-vitro secretion of MMP-2 in Mes1 cells both at 7 
and 14 days. Cell invasion, as measured by matrigel-coated filter, increased after 7 and 14 days infection with C. pneumoniae, 
compared with uninfected Mes1 cells. The results of this study suggest that C. pneumoniae infection might support cellular 
transformation, thus increasing lung cancer risk. [Int Microbiol 2014; 17(4):185-193]
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Introduction
Cancer is commonly defined as the uncontrolled growth of 
abnormal cells that have accumulated enough DNA damage 
to be freed from the normal restraints of the cell cycle. Al-
though viral infections have been strongly associated with 
cancer [34,35], bacterial associations are also significant. Im-
portant mechanisms by which bacterial agents may induce 
carcinogenesis include chronic infection, immune evasion, 
and immune suppression. Several pathogenic bacteria, par-
ticularly those that can establish a persistent infection, can 
promote or initiate abnormal cell growth by evading the im-
mune system or suppressing apoptosis [22]. In particular, 
some species or their toxins can alter host cell cycles or stim-
ulate the production of inflammatory substances linked to 
DNA damage [7,37]. A separate discussion applies to intracel-
lular pathogens that survive by evading the ability of the host 
to identify them as foreign.
Chlamydia pneumoniae is a Gram-negative bacillus and a 
compulsory intracellular parasite. Chlamydia pneumoniae in-
fection is acquired during childhood, and the prevalence grad-
ually increases to reach a maximum in middle age; it causes 
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respiratory infection in more than 50% of adults, leading to a 
higher incidence of pneumonia, as well as bronchitis, sinusi-
tis, rhinitis, and exacerbation of chronic obstructive pulmo-
nary disease [12]. The route of transmission is usually by 
aerosol and, in most cases, these infections are mild. The re-
sulting clinical course is acute symptomatic illness followed by 
chronic respiratory symptoms. After acute infection, C. pneu-
moniae intracellular life cycle is characterized by the develop-
ment of metabolically inert (antibiotic-resistant) atypical 
“persistent” inclusions. Persistent infection is a permanent 
source of bacterial antigen, promoting chronic inflammation; 
C. pneumoniae infections are thought to induce a state of per-
sistent inflammation [38]. It has been suggested that persistent 
C. pneumoniae inflammation would correlate with increased 
risk of lung cancer, by inducing chronic pulmonary inflamma-
tion [20,25]. In the complex framework of interactions be-
tween the infective agent and immune response, superoxide 
oxygen radicals, TNF-a, IL-1b and IL-8 play an essential role, 
contributing to lung tissue damage and DNA damage that 
eventually result in carcinogenesis [36]. 
The time between acquiring the infection and cancer de-
velopment is most often years or even decades as seen in can-
cers associated with Helicobacter pylori, Salmonella typhi, 
and Streptococcus bovis infections. The association of C. 
pneumoniae infection with lung cancer risk has been variable 
[21]; this could reflect the retrospective nature of some stud-
ies, small sample sizes, or inadequate adjustment for con-
founding due to smoking [27]. In addition, modest reliability 
of serologic assays and the lack of a validated marker for 
chronic infection have precluded an exact estimation of the 
etiologic role of C. pneumoniae [27]. Further information on 
the role of C. pneumoniae in lung cancer could be provided by 
studies using additional markers of infection and inflamma-
tion. The implementation of molecular biomarkers in the ear-
ly diagnosis of lung cancer has been a long standing goal. 
Particular focus was given in identifying such biomarkers in 
bronchial washings in individuals with a high risk of develop-
ing lung cancer [33]. 
Calretinin (CR) is a vitamin D-dependent calcium-binding 
protein involved in the physiological buffering of excess cyto-
solic calcium ions, calcium transport, and protection against 
calcium ion overload [42]. CR is expressed in a subpopulation 
of neurons in the central and peripheral nervous system and is 
consistently up-regulated in reactive mesothelial cells and in 
epithelioid malignant mesothelioma (MM). Until now CR has 
been mostly considered as a highly useful marker for the iden-
tification of MM and based on the fact that CR is not expressed, 
or it is undetectable, in normal mesothelial cells in vivo. 
The Wilms’ tumor gene 1 (WT1) is a major regulator of 
cell growth and development in the embryo kidney, adult uro-
genital system and central nervous system [41]. The transcrip-
tion factor WT1 has been found activated also in some human 
neoplasias, including Wilms tumor, gastrointestinal and pan-
creatobiliary tumors, urinary and male genital tumors, breast 
and female genital tumors, brain tumors, soft tissue sarcoma, 
osteosarcoma, malignant melanoma [32], and in mesothelio-
ma cells [2]. WT1 expression has been reported to be mark-
edly low in cells of normal healthy individuals, with the ex-
ception of the CD34+ hematopoietic progenitors [18]. WT1 
protein expression has been observed in endothelial cells dur-
ing angiogenesis, thus it can be a useful marker to distinguish 
between vascular proliferations and vascular malformations. 
Osteopontin (OPN) is a secreted phosphoglycoprotein that 
binds the integrin and CD44 families of receptors and plays a 
major role in tumorigenesis, tumor invasion, and metastasis 
[44]. Increasing data have shown that high expression levels 
of OPN are associated with invasion, progression, or metasta-
sis in malignant tumors of the pancreatic cancer, gastric can-
cer, liver cancer, and lung cancer [43]. 
Mesothelioma progression depends on an interaction with 
mesothelial cells that provide membrane-type 1 metallopro-
teinases (MT1-MMP) necessary to activate pro-matrix metal-
loproteinases 2 (pro-MMP-2) to facilitate migration through 
an extracellular matrix layer. In particular, MT1-MMP pre-
dominantly converts pro-MMP-2 to the intermediate forms 
but not to mature MMP-1 form. MMP-2 has been reported as 
a characteristic for pleural malignant mesothelioma, and has 
been suggested as a predictive marker for poor prognosis 
[14].
On the basis of the results reported in the literature, we 
were prompted to investigate if chlamydial infection could 
contribute to in vitro cellular transformation by up-regulating 
the gene expression of three known biomarkers of the on-go-
ing neoplastic transformation, that is CR, WT1 and OPN. 
Here we report experimental evidence that sustained C. pneu-
moniae infection may cause cellular transformation as evalu-
ated through the induced expression of CR, WT1 and OPN.
Materials and methods
Cell culture and treatments. Primary cultures of mesothelial cells 
(Mes1) were isolated and developed from pleural biopsy of a patient who was 
cytologically, histologically and immunohistochemically confirmed as hav-
ing non-malignant pleural mesotheliomas [4]. Tissue specimens were minced 
and incubated in growth medium 1:1 composition of DMEM and Ham’s F12 
medium (Invitrogen) supplemented with 20% fetal calf serum (GIBCO BRL. 
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Grand Island, NY), penicillin (0.1 mg/ml), streptomycin (0.1 mg/ml), epider-
mal growth factor (10 μg/ml), insulin (5 mg/ml) and hydrocortisone (0.2 mg/
ml). Cell cultures were incubated at 37°C in a humidified atmosphere of 5% 
CO2 for 14 days to achieve 75% confluence. Mes1 cells displayed a highly 
flattened cellular morphology composed of tightly packed non-overlapping 
cells, which covered the entire surface of the culture dish following conflu-
ence. Mes1 was analyzed by RT-PCR for the expression of carcinoembryonic 
antigen (CEA, negative marker), WT1, mesothelin and calretinin. 
Propagation of Chlamydia pneumoniae. Chlamydia pneumoniae 
(AR39) was propagated in HEp-2 cell monolayers as described by Roblin et 
al [39]. In brief, C. pneumoniae was inoculated onto a pre-formed monolayer 
of HEp-2 cells in 35-mm diameter wells, centrifuged at 1000 ×g at 25°C for 
60 min and incubated at 37°C with 5% CO2 for 1h. Supernatants were re-
placed with growth medium consisting of RPMI-1640 containing 1 mg/ml 
cycloheximide. Infected cultures were incubated at 37°C in 5% CO2 for 3 
days. Chlamydia pneumoniae was harvested by disrupting HEp-2 cells with 
glass beads followed by sonication and centrifugation at 250g to remove cel-
lular debris. Supernatants containing C. pneumoniae were further centrifuged 
at 20,000g for 20 min to pellet elementary bodies (EB). The EB pellet was 
then suspended in sucrose–phosphate–glutamate buffer, aliquoted and stored 
at -70°C. Infectivity titers of chlamydial stocks were evaluated by the titra-
tion of the inclusion-forming units (IFU) per millilitre in HEp-2 cells. These 
titers were used to determine the infectious doses for the cell line studied. 
Cell cultures and chlamydial stocks were confirmed to be free of Mycoplasma 
infections using 4,6-diamidino-2-phenylindole fluorescent staining (Sigma-
Aldrich S.r.l., Milan, Italy). In addition, contamination with Mycoplasma was 
excluded regularly by Mycoplasma-PCR using specific primers (MWG Bio-
tech, Martinsried, Germany). 
In vitro infection. Mes1 cells were seeded onto coverslips in 24-well 
plates at a density of 5 ×104 cells/well in the growth medium. The cells were 
then infected with C. pneumoniae by centrifugation at 1000g for 60 min at a 
multiplicity of infection (MOI) of 4 IFU/cell (a preliminary study showed this 
MOI to be the optimum rate) and incubated for 3 days. For some experiments, 
determinations were performed at 3 days post infection because of the com-
plicated, biphasic developmental cycle lasting up to 3 days. The count of IFU 
chlamydial was evaluated as described by Salin et al. [40]. In brief, at indi-
cated times, the medium was removed from the wells and the coverslips were 
washed twice with PBS and fixed in methanol for 10 min. The coverslips 
were allowed to dry and the chlamydial inclusions were stained with fluores-
cein isothiocyanate (FITC)-conjugated anti-MOMP monoclonal antibody 
(Dako Cytomation, Milan, Italy), according to manufacturer’s instructions. The 
stained inclusions were examined under a fluorescence microscope (Axioskop 2, 
Carl Zeiss, Milan, Italy) at 400×. The number of the formed inclusions was 
counted from four eye fields of each coverslips and calculated using the fol-
lowing formula: [(inclusions in control – inclusions in treated sample) / inclu-
sions in control] ×100.
                 
Cell proliferation and cell viability. Cell viability was evaluated 
with methyltetrazolium (MTT), which determines the activity of cellular (mi-
tochondrial) respiration, and can be considered as a metabolic rate of cells. 
Mes1 cultures were incubated with DMEM alone (negative control) or with 
C. pneumoniae (MOI  =  4) at 37°C in 5% CO2 . The number of living cells 
was determined by colorimetric MTT assay (3-[4.5-dimethyl-2.5 thia-
zolyl]-2.5 diphenyltetrazolium bromide; Sigma–Aldrich S.r.l.) according to 
the procedure of Boonyanugomol, et al. [3] after 3, 7 and 14 days. The ab-
sorbance of a formazan product in the tissue culture media was measured at 
650 nm using a microplate reader, and the results were expressed as the mean 
percentage of the control cells. MTT assay data were confirmed by counting 
infected and uninfected cells in a Bürker chamber. For viability evaluated by 
microscopy examination, the cells were observed at a magnification of 200× 
(CK 40 Olympus Microscope). The viability of the cells infected with C. 
pneumoniae and those of the controls were confirmed by the activity of the 
lactate dehydrogenase (LDH) released in the supernatants [10]. Briefly, 50 ml 
of the aliquots of cell supernatants were mixed with 25 ml of LDH reagent 
(Sigma-Aldrich S.r.l.) and incubated at room temperature for 30 min. The 
LDH activity was calculated by measuring the increase in absorbance at 490 
nm and was expressed as a percentage of the control values.
Morphological analysis. To monitor whether Mes1 cells were capable 
of supporting the growth of C. pneumoniae in vitro, at 3 days post infection, 
the infected cells were fixed with 100% methanol and stained for the inclu-
sion bodies using a fluorescein–isothiocyanate (FITC)-conjugated anti-
MOMP monoclonal antibody (Dako Cytomation, Milan, Italy). Morphologi-
cal features of Mes1 cells infected with C. pneumoniae were examined at a 
magnification of 400× by confocal fluorescence microscopy (Axioskop 2). 
Determinations were performed at MOI = 4 and after 3 days post infection 
because this multiplicity and time of infection had been found to be the best 
in preliminary experiments.
Real-time PCR analysis. Semi-confluent Mes1 cells (106 /well) were 
infected with C. pneumoniae for 7 and 14 days. Total RNA was isolated with 
the High Pure RNA Isolation Kit (Roche Diagnostics, Milan, Italy) from 
Mes1 cells, infected and non-infected with C. pneumoniae. Three hundred 
nanograms of total cellular RNA were reverse-transcribed (Expand Reverse 
Transcriptase, Roche Diagnostics) into complementary DNA (cDNA) using 
random hexamer primers (Random hexamers, Roche Diagnostics), at 42°C 
for 45 min according to the manufacturer’s instructions. Real-time PCR was 
carried out with the LC Fast Start DNA Master SYBR Green kit (Roche Di-
agnostics; LightCycler 2.0 Instrument) using 2 ml of cDNA, corresponding to 
10 ng of total RNA in a 20 ml final volume, 3 mM MgCl2 and 0.5 mM each 
primer (final concentration). Primer sequences and annealing temperatures 
are shown in Table 1. A melting curve was made at the end of each amplifica-
tion to ensure the absence of non-specific reaction products. The accuracy of 
mRNA quantification depends on the linearity and efficiency of the PCR am-
plification. Both parameters were assessed using standard curves generated 
by increasing amounts of cDNA. Quantification was based on the threshold 
cycle values, measured in the early stage of the exponential phase of the reac-
tion. All quantifications were normalized to the housekeeping gene b-actin. 
The percentage of gene expression increase was calculated using the follow-
ing formula: [(gene expression in unstimulated conditions – target gene ex-
pression) / gene expression in unstimulated conditions] ×100.
Protein extraction and western blot analysis. Semi-confluent 
Mes1 cells (106 /well) were infected with C. pneumoniae for 7 and 14 days. 
Cells were scraped with 1 ml PBS, and the cell pellet was homogenized 
with 300 ml ice-cold buffer (50 mM HEPES, pH 7.5, 150 mM NaCl, 1% 
glycerol, 1% Triton, 1.5 mM MgCl2, 5 mM EGTA) supplemented with 20 mM 
sodium pyrophosphate, 40 mg/ml aprotinin, 4 mM PMSF, 10 mM sodium 
orthovanadate, 25 mM NaF. Total extracts were cleared by centrifugation at 
10,000 rpm for 30 min at 4°C and assayed for the protein content by Brad-
ford’s method. Fifty mg of protein from each cell lysate were separated by 
10% SDS-PAGE and transferred to nitrocellulose membranes. Filters were 
then stained with 10% Ponceau S solution for 2 min to verify equal loading 
and transfer efficiency. In addition, protein normalization was verified by 
densitometric analysis of bands. Blots were blocked overnight with 5% 
non-fat dry milk, then incubated with anti-MMP-2 (H-76) rabbit polyclonal 
antibody, OPN (sc-21742) mouse monoclonal, WT1 (sc-192) rabbit poly-
clonal, calretinin (sc-365956) mouse monoclonal and anti-tubulin mouse 
monoclonal antibody (Santa Cruz Biotechnology) 1:200 in TBS (150 mM 
NaCl, 20 mM Tris-HCl, pH 8) for 2 h at room temperature. After washing 
with 0.1% Tween-20 PBS, the filters were incubated with 1:2500 peroxi-
dase-conjugated anti-mouse or anti-rabbit immunoglobulins for 1 h at 
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22°C. They were extensively washed and finally analyzed using the ECL 
system (Amersham).
Gelatin zymography. Semi-confluent Mes1 cells were plated in 6-well 
plates (35 mm diameter) and infected with C. pneumoniae for 7 and 14 days. 
Gelatinolytic activity of MMP-2 was determinated using the method of Heus-
sen and Dowdle [13] adapted for minigel format. Conditioned media of each 
sample were centrifuged at 6000 rpm for 20 min and the protein content of the 
supernatant was estimated by Bradford’s method. Twenty mg of sample were 
mixed with an equal volume of 2×non-reducing sample buffer and each sam-
ple was separated by 10% (w/v) polyacrylamide gel containing 2 mg/ml of 
gelatine (Sigma). After electrophoresis, the gel was incubated in 2.5% Triton 
X-100 for 1hour to remove SDS and then overnight at 37°C in the developing 
buffer (50mM Tris-HCl, pH 7.6, containing 0.2 M NaCl, 5mM CaCl2 and 
0.02% (w/v) Brij-35). The gel was stained for 45 min in 40% methanol/10% 
glacial acetic acid containing 0.1% (w/v) Coomassie Brilliant Blue R 250 and 
de-stained in the same solution without Coomassie Brilliant Blue. 
Cell invasion assay. Cell invasion assays were carried out in Boyden 
chambers under serum-free conditions as previously described [1]. The 10-
mm pore-size-polycarbonate filters were coated with 5 mg/ml fibronectin and 
then with Matrigel (BD Bioscences) 25 mg/ml. After 14 days C. pneumoniae 
infection, Mes1 cells were trypsinized and placed in the upper compartment 
of the Boyden chamber in serum-free medium, and FBS 10% was placed in 
the lower compartment as the chemoattractant. Cells were allowed to attach 
and spread at 37°C in 5% CO2 for 24 h. The cells on the upper surface of the 
filter were completely removed by wiping with a cotton swab, while those 
that had traversed the Matrigel and attached to the lower surface of the filter 
were fixed in ethanol, stained with hematoxylin and counted in 10 random 
fields/filter at 200×. In parallel, the control cells were assessed for viability 
and counted with trypan blue. The number of cells that had invaded was nor-
malized to analyze the effects on cell viability.
Statistical analysis. Each experiment was performed at least three 
times. The results are expressed as means ± standard deviations (SD). Stu-
dent’s t test was used to determine statistical differences between the means, 
and P < 0.01 was considered a significant difference.
Results 
Mes1 cells proliferation and viability Chlamydia 
pneumoniae–infected. Confocal fluorescence micros-
copy using an anti-Chlamydia monoclonal antibody revealed 
that Mes1 cells had many intracellular inclusion bodies after 3 
days of infection (Fig. 1B) compared with control cells (Fig. 
1A), whereas at 1 and 2 days post infection the cells showed 
only few intracellular inclusion bodies (data not shown).
We examined the effect of C. pneumoniae infection on the 
proliferative activity of Mes1 cells, by both the colorimetric 
MTT and LDH assay. After 3 days exposure to C. pneumoniae, 
the cell number was slightly modified compared to test cultures 
and controls (Fig. 1C–E). After 7 days of incubation with 
C. pneumoniae, an increased proliferative activity was ob-
served. In particular, during this period, the proliferative re-
sponse of Mes1 cells incubated with C. pneumoniae, deter-
mined by colorimetric assay and cell counting, showed an in-
crease of 34.1% and 29.4%, respectively, compared to the cells 
alone (Fig. 1C,D), while the viability, determined by LDH ac-
tivity, increased by 35.2% compared to the control cells 
(Fig. 1E). After 14 days of incubation, cell proliferation and 
viability still increased reaching values of 40.9%, 37.8% and 
40.4%, respectively.
Expression of CR, WT1 and OPN in infected 
Chlamydia pneumoniae Mes1 cells. To investigate 
whether chlamydial infection might promote cellular transfor-
Table 1. Human sense and antisense primer sequences. Sequences and conditions of the oligonucleotide primers 
used in real time-PCR analysis
Sense and antisense sequences Conditions
5′-CATACTACGGATGTTTGACTT-3′
5′-TCACGCTCTCTGAGTCTGG-3′
40 cycles at 95°C for 5s
56°C for 8s, 72°C for 17s
5′-CTCTTGTACGGTCGGCATCT-3′
5′-CAGCTGGAGTTTGGTCATG-3′
40 cycles at 95°C for 5s
56°C for 8s, 72°C for 17s
5′-CACCTGTGCCATACCAGTTAAAC-3′
5′-GGTGATGTCCTCGTCTGTAGCATC-3′
40 cycles at 94°C for 5s
53°C for 11s, 72°C for 21s
5′-TGACGGTAAGGACGGACTC-3′
5′-TGGAAGCGGATTGGAAAC T-3′
40 cycles at 94°C for 5s
57°C for 7s, 72°C for  14s
5′-CTGGGCCATGCCCTGGGGCTC-3′
5′-CAGGAACAGAAGGCCGGGAGG-3′
40 cycles at 94°C  for 5s
64°C for 4s , 72°C for 8s
5′-TGACGGGGTCACCCACACTGTGCCCATCTA-3′
5′-CTAGAAGCATTGCGGTGGACGATGGAGGG-3′
40 cycles at 95°C  for 5s
64°C for 8s , 72°C for 20s
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mation we analysed CR and WT1 gene expression, two 
known biomarkers of the on-going neoplastic transforma-
tion. As shown in Fig. 2A and C, Mes1 cell infected for 14 
days showed a strong induction of CR and WT1 gene expres-
sion. Shorter period of infection (7 days) induced only a 
slight modification of the biomarkers. On contrary, pro-
longed period of infection (21 days) were not investigated 
since Mes1 cells morphology was modified, showing the 
typical feature of cell suffering (data not show). To reinforce 
the result obtained we went to analyse osteopontin (OPN) 
gene expression, a marker reported to play an important role 
in tumorigenesis. Our results demonstrated that OPN was 
also up-regulated in infected Mes-1 cells (Fig. 2E), resulting 
in a major increase after 14 days C. pneumoniae infection. 
Finally, the results obtained on CR, WT1 and OPN gene ex-
pression were all confirmed by western blot analysis (Fig. 2B, 
2D and 2F).
CR and WT1 overexpression increases the in 
vitro invasive potential of Mes1 cells. In order to 
evaluate whether CR and WT1 overexpression might favour 
cell invasion we examined gelatinase MMP-2 gene expres-
sion and its activator membrane type1-MMP (MT1-MMP). 
As shown  in Fig. 3A and 3B, MT1-MMP and MMP-2 gene 
expression were both induced after 7 and 14 days of Mes1 
cells infection. However, the expression of these genes was 
stronger after 14 days infection, as it happened for the other 
markers analyzed. Also western blot analysis (Fig. 3C) 
showed that MMP-2 pro-enzyme and the mature 62k-Da en-
zyme of MMP-2 were more strongly increased after 14 days 
in Mes1 infected cells, compared with the point at 7 days and 
the control, suggesting the activation of the gelatinase. To 
confirm the result obtained we analyzed by zymography 
whether C. pneumoniae affects the in-vitro secretion of MMP-
2 by Mes1 cells. As shown in Fig. 3D, MMP-2 secretion in-
creased after 7 days infection, with a stronger increase after 
14 days, compared with uninfected cells. 
To strengthen the results we had obtained, we investigated 
the ability of C. pneumoniae to increase Mes1 cell invasion. 
Cell invasion, as measured using a modified Boyden chamber 







Fig. 1. Representative experiments of Mes1 cells infected with Chlamydia pneumoniae. (A) untreated Mes1 cells. (B) three days after incubation the infected 
cells were fixed with methanol and stained for the inclusion bodies using an anti-Chlamydia monoclonal antibody. Intracellular inclusion bodies (arrow). Images 
were collected using confocal fluorescence microscopy at ×400 magnification. (C-E) effect of Mes1 cells infected or uninfected (Ctrl) with C. pneumoniae 
(MOI =  4) on proliferation (C); cell counts (D); and cell viability (E). (C) Proliferation was determined by a colorimetric MTT assay (OD at 650 nm) after 3, 
7 and 14 days of culture of infected and uninfected cells. Results are expressed as the mean percentage of control cells. Data are means ± SD of three different 
experiments. (E) Viability was determined by LDH activity and is expressed as percentage of control values after 3, 7 and 14 days culture of infected cells. 
Data are means ± SD of three independent experiments. The asterisk indicates a statistically significant difference between the experimental test and the control 
test. * P < 0.05 ** P < 0.01 versus Mes1 cells alone.
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days infection with C. pneumonia (26% and 60% respective-
ly), compared with uninfected Mes1 cells (Fig. 4). 
Discussion
Chlamydia pneumoniae infection has been suggested to be 
strongly associated with lung carcinoma. However, only se-
roepidemiological studies have indicated such a potential re-
lation [20]. In fact, high C. pneumoniae antibody titers have 
been observed in lung cancer. Specifically, high IgA against 
C. pneumoniae were reported to be correlated with squamous 
cell carcinomas and to a lesser extent with small cell carcino-
mas and adenocarcinomas of the lung [28]. To our knowledge, 
up to now there is not any report about C. pneumoniae infec-
tion inducing transformation of human mesothelial cells. 
In our study, Mes1 cells infected with C. pneumoniae 







Fig. 2. Real time PCR analysis using specific primers for CR (A), WT1 (C) and OPN (E). Mes1, cells infected or not 
(Ctrl) with Chlamydia pneumoniae for 7, 14 days; Ctrl, untreated Mes1 cells. The columns are the mean values from 
three independent experiments with three duplicates. Significant differences compared to untreated cells are indicated 
as follows: ** P  < 0.01. (B, D and F) western blot analysis of CR, WT1 and OPN in Mes1 cells after exposure to C. 
pneumoniae. Line 1, untreated cells; lines 2-3, Mes1 cells infected with C. pneumoniae for 7 and 14 days respectively. 
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the microorganism was able to invade and replicate in this 
cellular type. In addition, an increased proliferative activity 
was demonstrated in C. pneumoniae-infected Mes1 cells. It is 
known that C. pneumoniae infection causes irregular apopto-
sis in tissues by unknown mechanisms [5]. Apoptosis and cel-
lular proliferation have a pivotal role in carcinogenesis. Hy-
perproliferation simultaneously reduces the time available to 
repair mutations in DNA and also increases the risk of spon-
taneous mutation due to errors in DNA replication [29]. It has 
been reported that C. pneumonia infection of endothelial cells 
triggers both vascular smooth muscle cells proliferation and 
the mitogenic activity of platelet-derived growth factor. There 
is also evidence that C. pneumoniae infection in endothelial 
cells induces the production of different mediators of inflam-
mation, among which MMP, which contributes to plaque de-
stabilization [8]. Using molecular biomarkers for the early 
diagnosis of lung cancer has been a long standing objective. 
Particular focal point was given in identifying such biomark-
ers in bronchial washings in individuals with a high risk of 
developing lung cancer. The WT1 gene was originally identi-
fied as a tumor suppressor gene, recently proposed to act as a 
chameleon gene in malignancies, i.e. functioning also as an 
oncogene [17]. It is expressed in a small number of human 
tissues [31] and in various cancer cells [32]. The marker has 
been usually considered to be positive in mesothelioma. Cal-
retinin is one of the first markers that have proven to be useful 
in the diagnosis of malignant mesothelioma [9], it being posi-
tive in 80–100% of malignant mesotheliomas [23,30]. Meso-
thelin and calretinin are proteins strongly expressed in meso-
thelial cells and mesotheliomas, whereas WT1 is mainly ex-
pressed in mesothelioma cells [11]. The expression of meso-
thelin and calretinin in our primary cell culture confirmed the 
mesothelial differentiation (data not shown). Our results 
showed  a strong induction of CR and WT1 gene expression 
in Mes1-infected cells , thus confirming the ability of C. pneu-
moniae to induce cellular transformation. To further support 
our results, we analysed another marker of tumor progression, 








Fig. 3. Real time PCR analysis using specific primers for MT1-MMP (A) and MMP-2 (B). Mes1, cells infected or not (Ctrl) with Chlamydia 
pneumoniae for 7 and 14 days; Ctrl; untreated Mes1 cells. the columns are the mean values from three independent experiments with three 
duplicates. Significant differences compared to untreated cells are indicated as follows: * P < 0.05 and ** P < 0.01. (C): western blot analysis 
of MMP-2 in Mes1 cells after exposure to C. pneumoniae. Line 1, untreated cells; lines 2-3, Mes1 cells infected with C. pneumoniae for 7 
and 14 days respectively. (D) MMP-2 secretion in Mes1 cells after exposure to C. pneumoniae. Line 1, untreated cells; lines 2-3, Mes1 cells 
infected with C. pneumoniae for 7 and 14 days respectively. 
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pression in infected Mes1 cells. This result is of interest since 
OPN has been shown to bind and/or activate pro-matrix met-
alloproteinase-3 (pro-MMP-3) and pro-MMP-9, and to acti-
vate phosphatidylinositol 3-kinase (PI3K)/protein kinase B 
pathway, promoting cell migration and cell survival [16]. 
Thus, OPN might contribute to sustained cell proliferation by 
contrasting apoptotic cell death and the elimination of ac-
quired mutations. MMP-2 and its activator membrane type1-
MMP (MT1-MMP) are molecules known to be linked to ag-
gressive tumor progression, poor survival, and high risk for 
metastasis  [14,46]. Interestingly, our results demonstrated 
that MMP-2 and MT1-MMP gene expression were both in-
duced after 14 days of Mes1 cells infection. The results were 
confirmed measuring the enzymatic activity by zymography. 
Finally, we found out that C. pneumoniae influenced the inva-
sive behavior of Mes1 cells. 
The results here reported indicate that C. pneumoniae in-
fection might support cell transformation. Epidemiological 
data in the literature support the idea that C. pneumoniae in-
fection might trigger lung carcinoma. Laurila, et al. [24] re-
ported that C. pneumoniae infection was present principally 
in patients with small-cell and squamous cell carcinomas, 
among 230 smokers with lung carcinoma. According to some 
studies, smoking assists C. pneumoniae to invade the lung 
[20]. Chlamydia infection is believed to increase lung cancer 
risk by inducing chronic pulmonary inflammation. Inflamma-
tory mediators, while offering protection by destroying invad-
ing pathogens, can inhibit apoptosis and enhance cell prolif-
eration, both of which can promote mutation and carcinogen-
esis [19,26]. Another study suggests that chronic inflammation 
could be responsible for the observed link between Helicobac-
ter pylori and carcinogenesis [15]. Similarly, C. pneumoniae 
infection might represent a risk factor aggravating the condi-
tion, in particular, of some classes of workers exposed to as-
bestos fibres at high risk of developing mesothelioma. Note 
that many of the bacterial infections that support oncogenesis 
are often asymptomatic. When the pathways toward malig-
nancy start and when they become irreversible, though, are 
aspects not yet fully understood [6]. Two other intracellular 
bacteria, Mycoplasma fermentans and M. penetrans, phyloge-
netically close relatives of Chlamydiae, have been reported to 
transform C3H mouse embryo cells in vitro by a multistage 
progression characterized by C-myc mRNA over-expression 
[45]. 
Because lung carcinoma and mesothelioma usually carry 
a dismal prognosis, there is urgent need to develop early diag-
nostic markers and effective therapies against chronic C. 
pneumoniae infections. To our knowledge, this is the firs re-
port of C. pneumoniae infection inducing trasformation of hu-
man mesothelial cells, which supports the idea that C. pneu-
moniae infection might increase the risk of lung carcinoma. 
Further information on the role of C. pneumoniae in lung can-
cer could be provided by studies using additional markers of 
infection and inflammation.
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